These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7537400)

  • 21. [Acute cytomegalovirus infection and recurrent thrombopenia in an immunocompetent girl].
    Hernández-Sampelayo T; Navarro-Gómez ML; Cristóbal P; Cantalejo A; Zapatero M; Gómez-Campderá JA
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):638-9. PubMed ID: 8808486
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
    So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased late rejection in cytomegalovirus-immunoglobulin-M-positive heart transplantation patients.
    Bunke M; Ganzel B; Gardner C
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):44-5. PubMed ID: 7482819
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of a 6-week prophylactic ganciclovir regimen and the role of serial cytomegalovirus antibody testing in lung transplant recipients.
    Kelly JL; Albert RK; Wood DE; Raghu G
    Transplantation; 1995 Apr; 59(8):1144-7. PubMed ID: 7732561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Performance of the IgG avidity test in patients with cytomegalovirus disease].
    Lafarga B; Noguera FJ; Bolanos M; Pérez MC; Rodríguez H
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):190-5. PubMed ID: 9312277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic cytomegalovirus management strategies.
    Martin M
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):23-7. PubMed ID: 7482812
    [No Abstract]   [Full Text] [Related]  

  • 28. Early diagnosis of cytomegalovirus infection in renal transplantation.
    Feletti C; Musiani M; Bonomini V
    Proc Eur Dial Transplant Assoc; 1980; 17():473-7. PubMed ID: 6264422
    [No Abstract]   [Full Text] [Related]  

  • 29. Incidence and therapy of cytomegalovirus disease after liver transplantation.
    Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation.
    Delone P; Corkill J; Jordan M; Krapiva P; Ghasemian R; Sasaki T; Light JA
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):58-9. PubMed ID: 7482823
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G
    Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation.
    Emery VC; Cope AV; Sabin CA; Burroughs AK; Rolles K; Lazzarotto T; Landini MP; Brojanac S; Wise J; Maine GT
    J Infect Dis; 2000 Dec; 182(6):1610-5. PubMed ID: 11069231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.
    Baccard-Longere M; Freymuth F; Cointe D; Seigneurin JM; Grangeot-Keros L
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):429-31. PubMed ID: 11238233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus infection of the graft duodenum and urinary bladder after simultaneous pancreas-kidney transplantation.
    Jang HJ; Kim SC; Cho YP; Kim YH; Han MS; Han DJ
    Transplant Proc; 2004 Sep; 36(7):2200-2. PubMed ID: 15518799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation.
    Peltier MK; Filipovich AH; Bechtel M; Dirksen CL; Englund JA
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):112-5. PubMed ID: 1324529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of cytomegalovirus infection in recipients of renal transplantation].
    Fan J; Qian J; He Q; Ma WH; Chen JH; Zhou L; Cai T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):262-4. PubMed ID: 11986702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of cytomegalovirus infection in kidney recipients.
    Bilgin N; Karakayali H; Moray G; Akkoç H; Turan M
    Transplant Proc; 1996 Aug; 28(4):2314-5. PubMed ID: 8769233
    [No Abstract]   [Full Text] [Related]  

  • 40. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.